INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

For the key trials, our articles and recipes, read the Nutrition & Adequacy desk →

People assigned to a diet, food or program and measured.

1,226 studies · page 43 of 52

2000 / Intervention and cross-sectional studies

An uncooked vegan "living food" diet increased antioxidant levels and improved symptoms in patients with fibromyalgia and rheumatoid arthritis.

Interventions and cross-sectional studies examined an uncooked vegan diet ("living food" [LF]) rich in berries, fruits, vegetables, nuts, and sprouts in subjects with rheumatic disorders. LF consumption resulted in highly increased serum levels of beta and alpha carotenes, lycopene, lutein, vitamin C, and cholesterol-adjusted vitamin E, alongside increased urinary excretion of polyphenols. Patients with fibromyalgia experienced decreased joint stiffness and pain and improved self-experienced health, while rheumatoid arthritis patients showed similar positive responses supported by objective measures.

Hänninen , Kaartinen K, Rauma AL, et al. Toxicology, 2000. PMID 11156742

2000 / 3-month open-label study

Oral NADH supplementation for 3 months showed no evidence of cognitive improvement in patients with mild to moderate dementia.

Researchers conducted a 3-month open-label study administering 10 mg/day of oral reduced nicotinamide adenine dinucleotide (NADH) to 25 patients with mild to moderate dementia alongside their current cholinomimetic medication. Among the 19 patients who completed the study, no evidence was found for any cognitive effect assessed by established psychometric tests. The authors concluded that NADH is unlikely to produce cognitive improvements of the magnitude reported earlier.

Rainer M, Kraxberger E, Haushofer M, et al. J Neural Transm (Vienna), 2000. PMID 11459000

1999 / Crossover trial

High-glycemic-index meals increased subsequent voluntary food intake in obese teenage boys

Twelve obese teenage boys consumed low-, medium-, or high-glycemic-index test meals at breakfast and lunch during three crossover evaluations. Subsequent voluntary energy intake over five hours was 5.8 mJ after the high-glycemic meal, which was 53% higher than following the medium-glycemic meal (3.8 mJ) and 81% higher than after the low-glycemic meal (3.2 mJ). The high-glycemic meal also produced higher insulin, lower glucagon, lower postabsorptive glucose and fatty acids, and elevated epinephrine.

Ludwig DS, Majzoub JA, Al-Zahrani A, et al. Pediatrics, 1999. PMID 10049982

1999 / Crossover trial

Early postprandial thermogenesis relies on both sensory and metabolic factors, with sensory effects more pronounced in leaner individuals.

Nine healthy men were evaluated under four conditions on different days: eating a 2582 kJ meal, sensory stimulation with the meal (seeing, smelling, tasting), non-alimentary sensory stimulation, and intragastric tube feeding of the meal. Energy expenditure changes over midday rest were +12.0% for the meal, +3.2% for alimentary stimulation, -2.6% for non-alimentary stimulation, and +5.7% for tube feeding. The energy expenditure rise was significantly higher following the meal than after sensory stimulation alone or tube feeding (both P < 0.01). Furthermore, the increase in energy expenditure correlated negatively with BMI only after alimentary sensory stimulation (r = -0.700; P < 0.05).

Brondel L, Fricker J, Fantino M Int J Obes Relat Metab Disord, 1999. PMID 10094574

1999 / Randomized double-blind crossover trial

Curcumin administration significantly reduced gallbladder volume compared with placebo in healthy adults.

In a crossover trial of 12 healthy adults, researchers evaluated gallbladder volume following 20 mg of curcumin or placebo using ultrasound. Curcumin significantly decreased gallbladder volume relative to placebo, with reductions of 11.8 +/- 6.9% at 0.5 hours, 16.8 +/- 7.4% at 1.0 hour, 22.0 +/- 8.5% at 1.5 hours, and 29.3 +/- 8.3% at 2.0 hours.

Rasyid A, Lelo A Aliment Pharmacol Ther, 1999. PMID 10102956

1999 / Randomized crossover trial

Wheat bran did not affect cholesterol regardless of particle size or gluten content.

Two randomized crossover studies evaluated wheat bran in 24 hyperlipidemic and 24 predominantly normolipidemic individuals. Supplementation with 19 g per day of dietary fiber from wheat bran did not alter total, LDL, or HDL cholesterol irrespective of bran particle size or gluten levels. However, in the metabolic study, replacing carbohydrate with gluten was associated with a 13 +/- 4% reduction in serum triglycerides (p = 0.005).

Jenkins DJ, Kendall CW, Vuksan V, et al. J Am Coll Nutr, 1999. PMID 10204832

1999 / Randomized controlled trial

Daily supplementation with 1000 mg ascorbic acid decreased blood lead in smokers.

A randomized trial assigned 75 adult male smokers to receive daily placebo, 200 mg, or 1000 mg of ascorbic acid for four weeks. Blood lead levels dropped by 81% after one week in the 1000 mg group (p <= 0.001). Neither the placebo nor the 200 mg daily dose produced any changes in blood or urine lead levels.

Dawson EB, Evans DR, Harris WA, et al. J Am Coll Nutr, 1999. PMID 10204833

1999 / Controlled trial

Protein-rich midday meals elicited an acute increase in salivary free cortisol

Researchers measured salivary free cortisol in healthy men before and after high-protein midday meals (39% energy as protein) compared with a fasting day, and in healthy women consuming high-protein (32%) or low-protein (5%) meals. An acute increase in cortisol occurred following high-protein meals but not after the low-protein meal. The magnitude of this cortisol increase in women correlated significantly with poorer psychological well-being.

Gibson EL, Checkley S, Papadopoulos A, et al. Psychosom Med, 1999. PMID 10204975

1999 / Euglycemic-hyperinsulinemic clamp trial

Early reductions in muscle glucose-6-phosphate suggest free fatty acids primarily inhibit glucose transport/phosphorylation before whole-body uptake declines.

In seven healthy men, skeletal muscle metabolism was tracked via 31P nuclear magnetic resonance spectroscopy during euglycemic-hyperinsulinemic clamps under high, basal, and low free fatty acid (FFA) levels. Whole-body glucose uptake was approximately 20% lower after 140 minutes with basal and high FFAs (42.8 +/- 3.6 and 41.6 +/- 3.3 vs. control 52.7 +/- 3.3 micromol x kg(-1) x min(-1), P < 0.05). Intramuscular glucose-6-phosphate (G-6-P) was blunted at 45 minutes of high FFA exposure (184 +/- 17 vs. control: 238 +/- 17 micromol/l, P = 0.008) and remained lower at 180 minutes with high and basal FFAs versus control (P < 0.05). The authors conclude these early G-6-P patterns suggest FFAs primarily inhibit glucose transport/phosphorylation prior to reducing whole-body glucose disposal.

Roden M, Krssak M, Stingl H, et al. Diabetes, 1999. PMID 10334314

1999 / Controlled crossover trial

A meal with olive oil led to lower triacylglycerol and higher HDL-C and incretin responses compared with a butter meal in healthy subjects.

Ten young, lean, healthy individuals consumed three test meals: a control meal (energy-free soup plus 50 g carbohydrate), control plus 100 g butter, and control plus 80 g olive oil. No significant differences were seen in glucose, insulin, or fatty acid responses between the two fat-rich meals. Plasma triacylglycerol responses were highest after the butter meal, with chylomicron triacylglycerol rising 2.5-5-fold, and retinyl palmitate responses were higher and more prolonged after butter. In contrast, postprandial HDL-cholesterol concentrations, GLP-1, and GIP responses were higher after the olive oil meal than after the butter meal.

NANO counterpoint →

Thomsen C, Rasmussen O, Lousen T, et al. Am J Clin Nutr, 1999. PMID 10357731

1999 / Controlled clinical trial

Refined carbohydrate supplementation had limited impact on gastrointestinal Candida albicans colonization.

A two-phase study in 28 healthy volunteers evaluated refined carbohydrate intake and gastrointestinal Candida albicans colonization. Baseline habitual refined carbohydrate consumption did not correlate with fungal blastoconidia counts in mouthwash or fecal samples. Furthermore, consuming a high-sugar diet did not increase fungal sample positivity or overall candidal concentrations, although fecal counts rose in a subset of participants who had elevated baseline oral counts.

Weig M, Werner E, Frosch M, et al. Am J Clin Nutr, 1999. PMID 10357735

1999 / Controlled trial

Restricting access to palatable foods increased children's subsequent selection and consumption.

Two within-subjects experiments examined how limiting access to palatable snacks influenced children's behavior, food choices, and intake. Both studies demonstrated that restricting access intensified children's behavioral responses toward the targeted food. In the second experiment, restriction notably elevated children's subsequent selection and intake of that palatable item within the restricted environment.

Fisher JO, Birch LL Am J Clin Nutr, 1999. PMID 10357749

1999 / Randomized multicenter controlled feeding trial

Targeting specific nutrients to affect blood pressure yielded major differences in food groups and nutrient profiles among the three DASH trial diets.

The DASH trial was a randomized, multicenter, controlled feeding study comparing control, fruits and vegetables, and combination diets for 8 weeks following a 3-week control run-in. Sodium intake and body weight were held constant throughout. The control and fruits and vegetables diets had more oils, table fats, salad dressings, red meats, saturated fat, total fat, and cholesterol than the combination diet. Fruits and vegetables and combination diets had more fruits, juices, vegetables, nuts/seeds, magnesium, potassium, and fiber than control, with fewer sweets and sugary drinks. Distinct food patterns also caused substantial differences in vitamins A, C, E, folate, B-6, and zinc.

Karanja NM, Obarzanek E, Lin PH, et al. J Am Diet Assoc, 1999. PMID 10450290

1999 / Controlled trial

Green tea ingestion increased plasma and urine antioxidant power in healthy adults

In healthy adults, plasma and urine antioxidant status was evaluated after green tea consumption using the ferric reducing/antioxidant power assay. Plasma antioxidant power rose rapidly to a peak increase of roughly 4% at 40 minutes, showing a mean increase of 44 +/- 9 (SE) mumol/l, while urinary excretion peaked at 60 to 90 minutes. Water ingestion produced no increase in plasma or urine antioxidant measurements.

Benzie IF, Szeto YT, Strain JJ, et al. Nutr Cancer, 1999. PMID 10453446

1999 / Intervention study

Feeding coconut kernel with coconut oil reduced serum total and LDL cholesterol in human volunteers compared to coconut oil alone.

In human volunteers, consuming coconut kernel alongside coconut oil reduced serum total and LDL cholesterol compared to consuming coconut oil alone, an effect also seen in rats. In a subsequent rat experiment, isolated coconut kernel protein lowered cholesterol, phospholipids, and triglycerides in serum and most tissues compared to casein. Rats fed kernel protein exhibited increased hepatic degradation of cholesterol to bile acids, decreased esterification of free cholesterol, decreased intestinal cholesterogenesis, and decreased lipogenesis in the liver and intestine.

Padmakumaran Nair KG, Rajamohan T, Kurup PA Plant Foods Hum Nutr, 1999. PMID 10472790

1999 / Randomized controlled trial

Vitamin C and E supplementation lowered pre-eclampsia incidence in high-risk women.

A randomized trial assigned 283 women at elevated risk of pre-eclampsia to daily vitamin C (1,000 mg) and vitamin E (400 IU) or placebo starting at 16-22 weeks' gestation. Supplementation decreased the PAI-1/PAI-2 ratio by 21% (95% CI 4-35, p=0.015). Pre-eclampsia developed in 8% (11 of 141) of vitamin recipients compared to 17% (24 of 142) on placebo (adjusted OR 0.39, 95% CI 0.17-0.90, p=0.02).

Chappell LC, Seed PT, Briley AL, et al. Lancet, 1999. PMID 10485722

1999 / Randomized, double-blind, vehicle-controlled split-face trial

A 3-month daily regimen of topical ascorbic acid objectively and subjectively improved mild to moderately photodamaged facial skin.

Nineteen patients with mild to moderate facial photodamage applied topical ascorbic acid to one side of the face and a vehicle serum to the other daily for 3 months. Optical profilometry demonstrated a statistically significant 73.7% improvement in Ra and shadows north-south facial axis values favoring active treatment over vehicle control, along with a trend toward improvement in Rz (68.4% greater improvement). Clinical assessments showed significant improvements in fine wrinkling, tactile roughness, coarse rhytids, skin laxity/tone, sallowness/yellowing, and overall features. Subjective questionnaires (84.2% greater than control) and photographic assessments (57.9% greater than control) also showed statistically significant improvements.

Traikovich SS Arch Otolaryngol Head Neck Surg, 1999. PMID 10522500

1999 / Clinical crossover trial

More raw egg protein escapes small intestinal digestion and absorption than cooked egg.

Ten healthy volunteers ingested 25 g of stable isotope-labeled egg protein in either cooked or raw test meals. Small intestinal assimilation was bypassed by 5.73% of the cooked meal compared with 35.10% of the raw meal (P < 0.005). A significantly larger portion of the unabsorbed raw protein was detected as colonic fermentation metabolites in urine.

Evenepoel P, Claus D, Geypens B, et al. Am J Physiol, 1999. PMID 10564098

1999 / Comparative feeding study in volunteers

Daily dried nori increased urinary methylmalonic acid excretion in female volunteers, whereas equivalent raw nori did not.

Researchers investigated whether cobalamin in dried nori differs from raw nori. Human female volunteers were given either 40 g of dried nori daily or 320 g of raw nori daily (equivalent to 40 g dried by dehydrated weight) during a test period. Urinary methylmalonic acid excretion increased after dried nori consumption, but did not change after raw nori consumption. Paper chromatography showed 65% of cobalamin homologues in dried nori were cobalamin analogues, whereas 73% in raw nori were genuine cobalamin.

Yamada K, Yamada Y, Fukuda M, et al. Int J Vitam Nutr Res, 1999. PMID 10642899

1999 / Incomplete block design trial

Vegetable types and physical disruption altered plasma lutein, folate, and beta-carotene bioavailability.

Sixty-nine volunteers consumed four-day vegetable or beta-carotene-supplemented meals. Broccoli and green peas increased plasma beta-carotene by 28% (95% CI: 6.4, 55) and 26% (95% CI: 2.6, 54), while spinach had no effect despite higher content. All vegetables increased lutein and vitamin C. Disrupting the spinach matrix enhanced plasma lutein by 14% (95% CI: 3.7, 25) and folate by 10% (95% CI: 2.2, 18).

van het Hof KH, Tijburg LB, Pietrzik K, et al. Br J Nutr, 1999. PMID 10655967

1999 / Controlled trial

Tomato juice restored T-lymphocyte cytokine secretion suppressed by a low-carotenoid diet.

Twenty-three non-smoking men followed a 2-week low-carotenoid diet followed by sequential 2-week periods consuming tomato juice, carrot juice, and spinach powder. The low-carotenoid period significantly suppressed peripheral blood mononuclear cell proliferation and cytokine secretion (IL-2, P < 0.001; IL-4, P < 0.05). Adding tomato juice restored IL-2 (P < 0.001) and IL-4 (P < 0.05) secretion, whereas carrot juice and spinach powder produced no significant changes.

Watzl B, Bub A, Brandstetter BR, et al. Br J Nutr, 1999. PMID 10673911

1999 / Intervention trial (pre-post)

A low-fat diet intervention significantly reduced migraine headache frequency, intensity, duration, and medication intake in migraine patients.

A 12-week study evaluated the impact of limiting dietary fat to no more than 20 g/day in 54 migraine patients following a 28-day baseline and a 28-day run-in period. Participants significantly decreased dietary fat intake from baseline (mean 65.9 g/day) to the final 28-day postintervention period (mean 27.8 g/day, p < 0.0001). The reduction in dietary fat was associated with statistically significant decreases in headache frequency, intensity, duration, and medication intake (all p < 0.0001). A significant positive correlation was also observed between baseline fat intake and headache frequency (r = .44, p = 0.02).

Bic Z, Blix GG, Hopp HP, et al. J Womens Health Gend Based Med, 1999. PMID 10839648

1999 / Clinical trial

Polyphenol-containing beverages dose-dependently inhibited non-haem iron absorption from a bread meal in adult humans.

The effects of various polyphenol-containing beverages on iron absorption from a bread meal were assessed in adults using erythrocyte incorporation of radio-Fe. All tested beverages dose-dependently reduced iron absorption relative to water; beverages with 20-50 mg total polyphenols/serving reduced absorption by 50-70%, while those with 100-400 mg/serving reduced absorption by 60-90%. Specific inhibition was 79-94% for black tea, 84% for peppermint tea, 73% for pennyroyal, 71% for cocoa, 59% for vervain, 52% for lime flower, and 47% for camomile. Adding milk to coffee and tea showed little or no effect on their inhibitory action.

Hurrell RF, Reddy M, Cook JD Br J Nutr, 1999. PMID 10999016

1999 / Double-blind, placebo-controlled trial

Intravenous GLP-1 infusions dose-dependently reduced food, calorie, and fluid intake in healthy men.

Sixteen healthy male volunteers received graded intravenous doses (0, 0.375, 0.75, and 1.5 pmol/kg/min) of synthetic human GLP-1 in a double-blind, placebo-controlled setup. Graded GLP-1 infusions caused a dose-dependent reduction in food intake (maximal inhibition 35%, p<0.001 vs control), calorie intake (32% reduction, p<0.001), and fluid ingestion (18% reduction, p<0.01). At the highest dose, participants reported less hunger and early fullness prior to a meal (p<0.05), with no overt side effects observed.

Gutzwiller JP, Göke B, Drewe J, et al. Gut, 1999. PMID 9862830